Alectinib, as a targeted drug for ALK positive non-small cell lung cancer, is contraindicated for individuals with severe liver function impair...
Alectinib, as a targeted drug for ALK positive non-small cell lung cancer, should be adjusted according to individual patient conditions in ter...
Ambrisentan is an endothelin receptor antagonist primarily used for the treatment of pulmonary arterial hypertension. Its common side effects i...
Ambrisentan is a selective endothelin receptor antagonist mainly used for the treatment of pulmonary arterial hypertension, and special attenti...
Apalutamide is an androgen receptor inhibitor used to treat prostate cancer, and its use is subject to specific contraindications, food restric...
Apalutamide is an androgen receptor inhibitor used to treat prostate cancer, and its use is subject to specific contraindications, food restric...
Pomalidomide is an immunomodulatory agent primarily used for the treatment of multiple myeloma, with dual anti-tumor and immunomodulatory effec...
Pomalidomide is a third-generation immunomodulatory agent mainly used for the treatment of relapsed/refractory multiple myeloma, with significa...
Lenalidomide has shown significant efficacy in hematological tumors such as multiple myeloma, but strict adherence to discontinuation guideline...
Lenalidomide, as an immunomodulatory agent, exerts anti-tumor and immunomodulatory effects through multiple mechanisms, and its drug interactio...